Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aquestive Therapeutics Q2 EPS $(0.14) Beats $(0.17) Estimate, Sales $10.003M Miss $11.320M Estimate

Author: Benzinga Newsdesk | August 11, 2025 03:02pm
Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.17) by 18.13 percent. This is a 366.67 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $10.003 million which missed the analyst consensus estimate of $11.320 million by 11.63 percent. This is a 50.23 percent decrease over sales of $20.099 million the same period last year.

Posted In: AQST


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist